Episode summary

Dow Plunges 900 Points On Salesforce Carnage: Paycom, Ascendis, TGTX In Focus | Stock Market Today

Stock Market Today With Ibd · · Hosts: Alissa Coram, Ken Shreve

Dow Plunges 900 Points On Salesforce Carnage: Paycom, Ascendis, TGTX In Focus | Stock Market Today – Stock Market Today With Ibd

Summary

Stocks sold off sharply as major indexes broke or tested key technical levels, with the Nasdaq composite down about 3/4 of a percent and the S&P 500 down a little over 1% before both finished off their lows. The Dow fell about 1.6%, the Russell 2000 made a fresh low, and breadth was weak across both the Nasdaq and NYSE. The discussion framed the day as a broad shakeout, with investors told to wait for a possible day one of a rally attempt rather than try to guess a bottom.

The weakest area was software, not semiconductors, with the IGV software ETF underperforming the SMH chip ETF and Salesforce leading a sharp drop in the Dow. Financials and healthcare also lagged, while the 10-year yield eased after October retail sales showed a mixed report. The host and a guest said Nvidia's earnings and the Fed minutes could be the next major catalysts, with Nvidia's conference call singled out as especially important.

Amid the turbulence, a few names held up better. Paycom stayed above its 50-day line and remained in a buy zone after earnings. Ascendis was highlighted as a profitable biotech with strong sponsorship and a double-bottom base, while TG Therapeutics was praised for its orderly low-volume pullback after a strong breakout.

Key takeaways

  • The guest said the Nasdaq's undercut of recent lows and close off the session low could set up a first day of a rally attempt, but not a confirmed bottom.
  • The S&P 500 and Dow both finished at or just below their 200-day moving averages, which the host said argues for caution.
  • Software stocks were the main source of selling pressure, with IGV falling about 3.3% versus a smaller drop in the semiconductor ETF.
  • Paycom stood out as a relative-strength name, still holding above its 50-day line and sitting in a buy zone after earnings.
  • Ascendis and TG Therapeutics were both flagged as profitable biotech names with strong technical setups and solid fund sponsorship.

Notable quotes

“this was a day of key levels for some of the indexes. Uh Ally, uh but yeah, tough day for software stocks”

— A speaker on Stock Market Today With Ibd at 0:28

“it still looks pretty uh pretty healthy here and it's in a you know it's in a good uh industry group inside of the enterprise software group”

— A speaker on Stock Market Today With Ibd at 22:15

Topics

  • dow selloff
  • salesforce earnings
  • stock market action
  • high-growth stocks
  • market leadership

Companies and tickers mentioned

  • CRM
  • PAYC
  • ASND
  • TGTX
  • Salesforce
  • Paycom
  • Ascendis
  • TGTX

Watch the episode

Watch “Dow Plunges 900 Points On Salesforce Carnage: Paycom, Ascendis, TGTX In Focus | Stock Market Today” on YouTube

Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.

More from Stock Market Today With Ibd

All Stock Market Today With Ibd episodes →

Stock Market Today With Ibd, this episode and its artwork belong to their owners. Octagon is not affiliated with the show; this page is an independent summary.